Does Anything on This Label Actually Support "Digestive Support"?

"Digestive support" is what the FDA calls a structure/function claim: a statement about how an ingredient may affect the normal structure or function of the body, as opposed to a claim that a product treats or cures a disease. Structure/function claims are allowed on supplement labels without FDA pre-approval, as long as the required disclaimer appears alongside them, which is exactly why the asterisk and the statement in the corner exist (FDA). The claim does not have to be backed by a clinical trial of the finished product; it has to be truthful and not misleading, and the brand must have substantiation on file, which is not the same as published, peer-reviewed proof for that specific capsule.

Putting the two cases side by side, the fiber ingredients have the more direct research connection to a general digestive claim: fermentation by colon bacteria is, by definition, digestive-tract activity, and it is documented at the ingredient level (inulin specifically) rather than only at the level of a single trial of one strain. The probiotic blend's lead trial is real and peer-reviewed, but it measured a metabolic outcome, not a digestive one, and the label's lack of CFU disclosure makes it harder to say how much of that trial's dose is even present in one Sodatide capsule.

That does not mean the probiotic blend is irrelevant to gut health in a broader sense — bacteria that live in the digestive tract are inherently part of digestive biology. It means that, specifically for the "digestive support" wording on this label, the fiber ingredients are the stronger evidentiary match.

U.S. supplement law recognizes a few distinct categories of label claim, and the differences matter for reading "Metabolic & Digestive Support*" correctly. A disease claim states or implies a product treats, prevents or cures a specific disease, such as "relieves irritable bowel syndrome." Disease claims require FDA drug-level review and are not permitted on a dietary supplement label without it. A structure/function claim, by contrast, describes a general effect on the body's normal structure or function, such as "supports digestive health," without naming a disease.

"Metabolic & Digestive Support" sits squarely in the structure/function category: it names body systems in general terms rather than a condition. The law allows this category specifically because it is broader and less specific than a disease claim, which is also why it carries a lighter evidentiary bar than a drug claim would, balanced by the required disclaimer that the statement has not been FDA-evaluated.

None of the research above was conducted on the finished Sodatide capsule. The fermentation research establishes a mechanism for inulin and resistant starch broadly; it does not prove that 311 mg of these two fibers in one capsule produces a noticeable digestive effect for any individual. The Akkermansia trial establishes a real, peer-reviewed metabolic finding for a specific dose of one strain; it does not establish a digestive-support outcome, and the label's undisclosed CFU count means the trial's dose cannot be matched to this product. For the full, ingredient-by-ingredient research comparison, see the Sodatide ingredients page.

Reading a label's structure/function claim alongside its actual disclosed ingredient amounts, rather than taking the claim at face value, is a habit that applies well beyond this one product; it is the same approach used throughout this site's label-literacy coverage. The same two-step habit — read the exact claim, then check it against the specific amounts on the panel — works for any supplement label, not only this one.